Otolaryngology/Head and Neck (all articles) | Links Medicus Content Curation & Alerts in Medicine

Systematic Review: Chemotherapy for the treatment of oral cavity and oropharyngeal cancer.

13 Jan, 2022 | 08:14h | UTC

Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy – Cochrane Library

Summary: Chemotherapy for mouth and throat cancer – Cochrane Library

RCT: Endoscopic sinus surgery with medical therapy vs. medical therapy alone for chronic rhinosinusitis with nasal polyps.

12 Jan, 2022 | 08:51h | UTC

Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

Commentary on Twitter

NEW Research—Endoscopic sinus surgery + medical therapy > medical therapy alone in pts w/ chronic rhinosinusitis w/ nasal polyps (although minimal clinically important difference was not met)

From Wytske Fokkens & colleagues https://t.co/VKxCQZ97Am pic.twitter.com/IzXq712lNL

— The Lancet Respiratory Medicine (@LancetRespirMed) January 8, 2022

Systematic Review: Antibiotics for adults and children with sore throats.

10 Dec, 2021 | 10:02h | UTC

Summary: Antibiotics for adults and children with sore throats – Cochrane Library

Original Research: Antibiotics for treatment of sore throat in children and adults – Cochrane Library

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

7 Dec, 2021 | 10:23h | UTC

The Risk of Postoperative Complications following Major Elective Surgery in Active or Resolved COVID-19 in the United States – Annals of Surgery

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

Choosing Wisely: Nine pediatric otolaryngology recommendations.

9 Nov, 2021 | 01:09h | UTC

Choosing Wisely Canada – pediatric otolaryngology recommendations – Journal of Otolaryngology – Head & Neck Surgery

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

Choosing Wisely for Thyroid Conditions: Ten things clinicians and patients should question – “Do not order thyroid ultrasound for nodule detection in patients without thyroid anatomic anomalies on clinical examination”.

9 Nov, 2021 | 01:11h | UTC

Choosing Wisely for Thyroid Conditions: Recommendations of the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

Retrospective cohort study: corticosteroid treatment linked to lower odds of surgical drainage among pediatric patients with retropharyngeal and parapharyngeal abscesses.

28 Oct, 2021 | 09:52h | UTC

Corticosteroids in the Treatment of Pediatric Retropharyngeal and Parapharyngeal Abscesses – Pediatrics

Clinical Report | Topical nasal decongestant Oxymetazoline: safety considerations for perioperative pediatric use.

6 Oct, 2021 | 10:01h | UTC

Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use – Pediatrics

AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.

23 Sep, 2021 | 10:02h | UTC

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association – Journal of the American Heart Association

News release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association

RCT: Prophylactic steroids prevent hypocalcemia and voice dysfunction in patients undergoing thyroidectomy.

15 Sep, 2021 | 08:44h | UTC

Use of Prophylactic Steroids to Prevent Hypocalcemia and Voice Dysfunction in Patients Undergoing Thyroidectomy: A Randomized Clinical Trial – JAMA Otolaryngology – Head & Neck Surgery (link to abstract – $ for full-text)

Author interview: Prophylactic Steroids for Postthyroidectomy Hypocalcemia and Voice Dysfunction

Commentary: IV Steroid Before Thyroidectomy Prevents Complications — One dose of dexamethasone reduced hypocalcemia, voice issues – MedPage Today (free registration required)

Commentary on Twitter

This RCT with 192 patients found that pre-op dexamethasone resulted in a reduction in hypocalcemia at 24 hrs post-op by 24% and reduction in voice dysfunction at 24 hrs by 25%. Strong evidence in supporting a pre-op 8mg dose of dexamethasone @JAMAOto https://t.co/UIt18DXclN

— Jay Piccirillo, MD (@PiccirilloJay) September 5, 2021

Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study.

6 Sep, 2021 | 10:36h | UTC

Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study – Academic Emergency Medicine (link to abstract – $ for full-text)

Commentary: Can We Detect Central Vertigo on Exam? – Journal Feed

Study: Macrolide use significantly associated with both prevalent and incident tinnitus.

22 Aug, 2021 | 22:11h | UTC

Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss – Journal of Antimicrobial Chemotherapy

Commentary: Macrolide Use and Tinnitus: A New Safety Ringtone? – NEJM Journal Watch (free for a limited period)

ASCO Guideline: Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies.

19 Aug, 2021 | 08:50h | UTC

Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline – Journal of Clinical Oncology

Review: Initial management of blunt and penetrating neck trauma.

17 Aug, 2021 | 08:40h | UTC

Initial management of blunt and penetrating neck trauma – BJA Education

Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes.

6 Aug, 2021 | 10:09h | UTC

Mucormycosis after COVID-19 in a patient with diabetes – The Lancet

COVID-19 and mucormycosis superinfection: the perfect storm.

ECMM/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries.

The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring blood glucose levels are some of the strategies suggested by the authors.

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India – Uncontrolled diabetes mellitus was the most common underlying disease; improper glucocorticoid use was independently associated with the disease.

Opinion | “Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing” – improper use of antibiotics and higher than usual doses of corticosteroids may be contributing to the emergence of mucormycosis and other fungal co-infections.

What is mucormycosis, the fungal infection affecting COVID patients in India?

[Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries.

Mucormycosis: The ‘black fungus’ maiming Covid patients in India

Global Guideline for the Diagnosis and Management of Mucormycosis

Post-viral effects of COVID-19 in the olfactory system and their implications.

2 Aug, 2021 | 00:24h | UTC

Post-viral effects of COVID-19 in the olfactory system and their implications – The Lancet Neurology

Study finds 96.1% of patients objectively recovered from anosmia 1 year after COVID-19 diagnosis.

Eight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).

Loss of smell in mild Covid-19 cases occurs 86% of the time, study says

Management of anosmia and loss of smell in the era of Covid-19

Severe hearing loss in adults: finding out whether cochlear implants or hearing aids are better.

16 Jul, 2021 | 10:27h | UTC

Severe hearing loss in adults: finding out whether cochlear implants or hearing aids are better – Evidently Cochrane Blog

Commentary on Twitter

Severe hearing loss in adults: finding out whether #CochlearImplants or #HearingAids are better: https://t.co/II0l1G74ny In a new @CochraneUK blog, Dr Adele Horobin from @NottmBRC discusses @COACH_trial, a new clinical trial seeking to find an answer. #LivingWithLTCs #HearingLoss pic.twitter.com/4Tx4jUC1KO

— The Cochrane Library (@CochraneLibrary) July 7, 2021